CDK4/6InhibitorsACChemotherapyLCISTamoxifenCytostaticNeoadjuvantTherapyCapecitabineAntibodyTherapyAdjuvantTherapyRelapseCAMlatissimusflapEstrogenFibroadenomaLapatinibMastectomyNeoplasmBevacizumabPaclitaxelMegestrolAcetateMRIBilateralProphylacticMastectomyLumpectomyNodeNegativeBenignPhyllodesTumorEGFR(epidermalgrowth factorreceptor)MastalgiaCyclophosphamideCo-survivorLymphoscintigraphyECOGScoreMolecularBreastImagingMetastasisApoptosisPalbociclibCalcificationsFamilyHistoryAyurvedaBRCAGene5-FluorouracilGermlineMutationBOCAWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.EndometrialCancerAntiemeticAromataseInhibitorsAxillarySamplingPhyllodesTumorTriplePositiveBreastCancerImmunotherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyGeneticPredispositionMastodyniaDiabeticMastopathyMethotrexateER-KappaEpsilonBrachytherapyDown-StagingHormoneReplacementTherapyGailModelFlowCytometryMultifocalTumorsDisease-FreeSurvivalRateMastitisBreastCancerSclerosingAdenosisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPalpationTumorGrade1 in 8womenPARPInhibitorsMorpheaMultimodalityTherapyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearRaloxifeneLumpCystMetastaticBreastCancerNodePositiveDefinitiveSurgeryBI-RADSMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltSERMTyrosine-KinaseInhibitorOligometastasesProgestinmTORInhibitorsGeneMutationLymphNodeStatusEvidencesuggests thatphysical activitymay reduce therisk of breastcancersAlopeciaSelf-examinationRADOvarianSuppressionCytotoxicAnastrozoleBreastTomosynthesisStagingPrecisionMedicineIn-situCarcinomaCheckpointInhibitorHER-2DocetaxelOophorectomyExcisionalBiopsyAngiogenesisChemopreventionAdenocarcinomaHerceptinPathologicResponseER+BiopsyLiquidBiopsyDoxorubicinGenomicTestingCachexiaGuaranteedRenewableInsuranceFISHDoseDenseTherapyEstradiolHormoneReceptorStatusAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTripleNegativeBreastCancerKi-67RateChemotherapyInvasiveBreastCancerGeneticCounselingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AdvocacyPagetDiseaseAbsoluteRiskPI3KinaseInhibitorsIntraductalPapillomaDimplingCMFChemotherapyRadiotherapyCDK4/6InhibitorsACChemotherapyLCISTamoxifenCytostaticNeoadjuvantTherapyCapecitabineAntibodyTherapyAdjuvantTherapyRelapseCAMlatissimusflapEstrogenFibroadenomaLapatinibMastectomyNeoplasmBevacizumabPaclitaxelMegestrolAcetateMRIBilateralProphylacticMastectomyLumpectomyNodeNegativeBenignPhyllodesTumorEGFR(epidermalgrowth factorreceptor)MastalgiaCyclophosphamideCo-survivorLymphoscintigraphyECOGScoreMolecularBreastImagingMetastasisApoptosisPalbociclibCalcificationsFamilyHistoryAyurvedaBRCAGene5-FluorouracilGermlineMutationBOCAWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.EndometrialCancerAntiemeticAromataseInhibitorsAxillarySamplingPhyllodesTumorTriplePositiveBreastCancerImmunotherapyWomen ages40+ shouldhave a clinicalbreast examat least yearlyGeneticPredispositionMastodyniaDiabeticMastopathyMethotrexateER-KappaEpsilonBrachytherapyDown-StagingHormoneReplacementTherapyGailModelFlowCytometryMultifocalTumorsDisease-FreeSurvivalRateMastitisBreastCancerSclerosingAdenosisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerPalpationTumorGrade1 in 8womenPARPInhibitorsMorpheaMultimodalityTherapyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearRaloxifeneLumpCystMetastaticBreastCancerNodePositiveDefinitiveSurgeryBI-RADSMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltSERMTyrosine-KinaseInhibitorOligometastasesProgestinmTORInhibitorsGeneMutationLymphNodeStatusEvidencesuggests thatphysical activitymay reduce therisk of breastcancersAlopeciaSelf-examinationRADOvarianSuppressionCytotoxicAnastrozoleBreastTomosynthesisStagingPrecisionMedicineIn-situCarcinomaCheckpointInhibitorHER-2DocetaxelOophorectomyExcisionalBiopsyAngiogenesisChemopreventionAdenocarcinomaHerceptinPathologicResponseER+BiopsyLiquidBiopsyDoxorubicinGenomicTestingCachexiaGuaranteedRenewableInsuranceFISHDoseDenseTherapyEstradiolHormoneReceptorStatusAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTripleNegativeBreastCancerKi-67RateChemotherapyInvasiveBreastCancerGeneticCounselingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AdvocacyPagetDiseaseAbsoluteRiskPI3KinaseInhibitorsIntraductalPapillomaDimplingCMFChemotherapyRadiotherapy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. CDK4/6 Inhibitors
  2. AC Chemotherapy
  3. LCIS
  4. Tamoxifen
  5. Cytostatic
  6. Neoadjuvant Therapy
  7. Capecitabine
  8. Antibody Therapy
  9. Adjuvant Therapy
  10. Relapse
  11. CAM
  12. latissimus flap
  13. Estrogen
  14. Fibroadenoma
  15. Lapatinib
  16. Mastectomy
  17. Neoplasm
  18. Bevacizumab
  19. Paclitaxel
  20. Megestrol Acetate
  21. MRI
  22. Bilateral Prophylactic Mastectomy
  23. Lumpectomy
  24. Node Negative
  25. Benign Phyllodes Tumor
  26. EGFR (epidermal growth factor receptor)
  27. Mastalgia
  28. Cyclophosphamide
  29. Co-survivor
  30. Lymphoscintigraphy
  31. ECOG Score
  32. Molecular Breast Imaging
  33. Metastasis
  34. Apoptosis
  35. Palbociclib
  36. Calcifications
  37. Family History
  38. Ayurveda
  39. BRCA Gene
  40. 5-Fluorouracil
  41. Germline Mutation
  42. BOCA
  43. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  44. Endometrial Cancer
  45. Antiemetic
  46. Aromatase Inhibitors
  47. Axillary Sampling
  48. Phyllodes Tumor
  49. Triple Positive Breast Cancer
  50. Immunotherapy
  51. Women ages 40+ should have a clinical breast exam at least yearly
  52. Genetic Predisposition
  53. Mastodynia
  54. Diabetic Mastopathy
  55. Methotrexate
  56. ER-
  57. Kappa Epsilon
  58. Brachytherapy
  59. Down-Staging
  60. Hormone Replacement Therapy
  61. Gail Model
  62. Flow Cytometry
  63. Multifocal Tumors
  64. Disease-Free Survival Rate
  65. Mastitis
  66. Breast Cancer
  67. Sclerosing Adenosis
  68. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  69. Palpation
  70. Tumor Grade
  71. 1 in 8 women
  72. PARP Inhibitors
  73. Morphea
  74. Multimodality Therapy
  75. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  76. Raloxifene
  77. Lump
  78. Cyst
  79. Metastatic Breast Cancer
  80. Node Positive
  81. Definitive Surgery
  82. BI-RADS
  83. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  84. SERM
  85. Tyrosine-Kinase Inhibitor
  86. Oligometastases
  87. Progestin
  88. mTOR Inhibitors
  89. Gene Mutation
  90. Lymph Node Status
  91. Evidence suggests that physical activity may reduce the risk of breast cancers
  92. Alopecia
  93. Self-examination
  94. RAD
  95. Ovarian Suppression
  96. Cytotoxic
  97. Anastrozole
  98. Breast Tomosynthesis
  99. Staging
  100. Precision Medicine
  101. In-situ Carcinoma
  102. Checkpoint Inhibitor
  103. HER-2
  104. Docetaxel
  105. Oophorectomy
  106. Excisional Biopsy
  107. Angiogenesis
  108. Chemoprevention
  109. Adenocarcinoma
  110. Herceptin
  111. Pathologic Response
  112. ER+
  113. Biopsy
  114. Liquid Biopsy
  115. Doxorubicin
  116. Genomic Testing
  117. Cachexia
  118. Guaranteed Renewable Insurance
  119. FISH
  120. Dose Dense Therapy
  121. Estradiol
  122. Hormone Receptor Status
  123. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  124. Triple Negative Breast Cancer
  125. Ki-67 Rate
  126. Chemotherapy
  127. Invasive Breast Cancer
  128. Genetic Counseling
  129. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  130. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  131. Advocacy
  132. Paget Disease
  133. Absolute Risk
  134. PI3 Kinase Inhibitors
  135. Intraductal Papilloma
  136. Dimpling
  137. CMF Chemotherapy
  138. Radiotherapy